Diciembre 2024. Volumen 20. Número 4

Otros artículos seleccionados y no valorados críticamente

 
 
 
 
 
 
 
 
 
 
Valoración: 0 (0 Votos)
Suscripción gratuita al boletín de novedades
Reciba periódicamente por correo electrónico los últimos artículos publicados
Suscribirse
Imprimir
Añadir a biblioteca
Comentar este artículo

OTR | Otros artículos seleccionados y no valorados críticamente

Autor: .
Correspondencia: . Correo electrónico:
Fecha de aceptación:
Fecha de publicación:

OTR | Otros artículos seleccionados y no valorados críticamente

Contenido del artículo

Área Clínica

Referencia bibliográfica

Puntuación
escala
ESEARTE

Tratamiento

Jang J, Krishnamurthy J, Nylund CM. Association between celiac disease and pneumococcal infections in hospitalized pediatric patients in the United States. J Pediatr gastroenterol Nutr.2024;79:335-42. 41
Erlacher R, Toepfner N, Dressen S, Berner R, Bösch A, Tenenbaum T, Heininger U. Are Invasive Group A Streptococcal Infections Preventable by Antibiotic Therapy?: A Collaborative Retrospective Study. Pediatr Infect Dis J. 2024;43:931-35. 38
Alsabri M, Hafez AH, Singer E, Elhady MM, Waqar M, Gill P. Efficacy and Safety of Intranasal Fentanyl in Pediatric Emergencies: A Systematic Review and Meta-analysis. Pediatr Emerg Care. 2024; 40:748-52.
41
Castro-Rodriguez JA, Turi KN, Forno E. A critical analysis of the effect of OM-85 for the prevention of recurrent respiratory tract infections or wheezing/asthma from systematic reviews with meta-analysis. Pediatr Allergy Immunol. 2024;35:e14186 28
Jensen EA, DeMauro SB, Rysavy MA, Patel RM, Laughon MM, Eichenwald EC, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Acetaminophen for Patent Ductus Arteriosus and Risk of Mortality and Pulmonary Morbidity. Pediatrics. 2024;154:e2023065056. 33
Andina Martínez D, Claret Teruel G, Gijón Mediavilla M, Cámara Otegui A, Baños López L, de Miguel Lavisier B, et al; Impact of universal Respiratory Syncytial Virus prophylaxis in Spain Working Group. Nirsevimab and Acute Bronchiolitis Episodes in Pediatric Emergency Departments. Pediatrics.2024;154:e2024066584. 37
De la Cruz-Mena JE, Veroniki AA, Acosta-Reyes J, Estupiñán-Bohorquez A, Ibarra JA, Pana MC, et al. Short-term Dual Therapy or Mono Therapy With Acetaminophen and Ibuprofen for Fever: A Network Meta-Analysis. Pediatrics. 2024;154:e2023065390. 42
Zhao Y, Gao Y, Guyatt G, Uyeki TM, Liu P, Liu M, et al. Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis. Lancet. 2024;404:764-72. 40
Ares-Gómez S, Mallah N, Santiago-Pérez MI, Pardo-Seco J, Pérez-Martínez O, Otero-Barrós MT, et al; NIRSE-GAL study group. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study. Lancet Infect Dis. 2024;24:817-28. 43
van Boxel EJ, Rahman S, Lai K, Boulos N, Davis N. Semaglutide treatment for children with obesity: an observational study. Arch Dis Child. 2024;109:822-5 34
Coma E, Martinez-Marcos M, Hermosilla E, Mendioroz J, Reñé A, Fina F, et al. Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain). Arch Dis Child 2024;109:736–41.
40
Quigley M, Embleton ND, Meader N, McGuire W. Donor human milk for preventing necrotising enterocolitis in very preterm or very low-birthweight infants. Cochrane Database of Systematic Reviews 2024;9:CD002971. 38
Hahn D, Samuel SM, Willis NS, Craig JC, Hodson EM. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database of Systematic Reviews 2024;8:CD001533 38
Malec L, Peyvandi F, Chan AKC, Königs C, Zulfikar B, Yuan H, et al; XTEND-Kids Trial Group. Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A. N Engl J Med. 2024;391:235-46. 39
Sarafoglou K, Kim MS, Lodish M, Felner EI, Martinerie L, Nokoff NJ, et al; CAHtalyst Pediatric Trial Investigators. Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia. N Engl J Med. 2024;391:493-503. 38
Moise KJ Jr, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, et al.; UNITY Study Group. Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn. N Engl J Med. 2024;391:526-37. 36
Lendner N, Minich NM, Malay S, Sferra TJ, Young DD. Comparison of budesonide vehicles in inducing histologic remission in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr.2024;79:92-9. 35

Otras áreas

Román Villaizán ML, Seoane Sanz A, Sanz Cuesta T, Rodríguez Barrientos R, Alonso Safont T, Villaizán Pérez C, et al. Poor compliance with clinical practice guidelines in the management of asthma in primary care in the community of Madrid. An Pediatr (Engl Ed). 2024 Aug;101:84-94 37
Klein NP, Wiesner A, Bautista O, Group T, Kanu K, Li ZL, et al. Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine. Pediatrics. 2024;154:e2023064693. 40
Mütze U, Gleich F, Haas D, Urschitz MS, Röschinger W, Janzen N, et al. Vitamin B12 Deficiency Newborn Screening. Pediatrics. 2024;154:e2023064809. 37
Diallo AO, Wikswo ME, Sulemana I, Sahni LC, Boom JA, Ramani S, et al. Rotavirus Vaccine Effectiveness Against Severe Acute Gastroenteritis: 2009-2022. Pediatrics. 2024;154:e2024066879. 39

Pronóstico

Horvat C, Chauvel C, Casalegno JS, Benchaib M, Ploin D, Nunes MC; VRS Study Group in Lyon. RSV Severe Infection Risk Stratification in a French 5-Year Birth Cohort Using Machine-learning. Pediatr Infect Dis J. 2024;43:819-24. 36
Havens TN, LeBeau P, Calatroni A, Gern JE, O'Connor GT, Wood RA, et al. Viral and non-viral episodes of wheezing in early life and the development of asthma and respiratory phenotypes among urban children. Pediatr Allergy Immunol. 2024;35:e14197 38
Starnes JR, Crum K, George-Durrett K, Godown J, Parra DA, Markham LW, et al. Novel Cardiac Imaging Risk Score for Mortality Prediction in Duchenne Muscular Dystrophy. Pediatr Cardiol. 2024;45:1221-31. 35
Guz-Mark A, Aloi M, Scarallo L, Bramuzzo M, Escher JC, Alvisi P, et al; Porto IBD working group of ESPGHAN. Infantile and Very Early Onset Inflammatory Bowel Disease: A Multicenter Study. Pediatrics. 2024;154:e2023064546. 33
Wyrwa JM, Hoffberg AS, Stearns-Yoder KA, Lantagne AC, Kinney AR, Reis DJ, et al. Predicting Recovery After Concussion in Pediatric Patients: A Meta-Analysis. Pediatrics. 2024;154:e2023065431. 38

Diagnóstico

Kainth D, Prakash S, Sankar MJ. Diagnostic Performance of Machine Learning-based Models in Neonatal Sepsis: A Systematic Review. Pediatr Infect Dis J. 2024;43:889-901. 35
Serral G, Londoño-Cañola C, Continente X, Brugueras S, Sanchez-Martínez F, Ariza C. Prevalence of obesity and related factors in schoolchildren aged 3 to 4 years. An Pediatr (Engl Ed). 2024;101:3-13. 32
Murray Hurtado M, Martín Rivada Á, Pestano García S, Ramallo Fariña Y. Influence of the COVID-19 pandemic on the incidence of eating disorders. An Pediatr (Engl Ed). 2024;101:21-8 30
Klöti S, Schaad J, Spalinger J, Schibli S, Hart L, Sokollik C, et al. Outcome in pediatric celiac disease is independent of the diagnostic approach in patients with high antibody levels. J Pediatr Gastroenterol Nutr.2024;79:84-91. 36

Cómo citar este artículo

Otros artículos seleccionados y no valorados críticamente. Evid Pediatr. 2024;20:54.

Comentario asociado